Mitsuaki Sawano MD, PhD , Yilun Wu , Rishi M. Shah , Tianna Zhou , Adith S. Arun , Pavan Khosla , Shayaan Kaleem , Anushree Vashist , Bornali Bhattacharjee MS, PhD , Qinglan Ding PhD , Yuan Lu ScD , César Caraballo MD , Frederick Warner PhD , Chenxi Huang PhD , Jeph Herrin PhD , David Putrino PhD , Teresa Michelsen PhD , Liza Fisher , Cynthia Adinig , Akiko Iwasaki PhD , Harlan M. Krumholz MD, SM
{"title":"Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort","authors":"Mitsuaki Sawano MD, PhD , Yilun Wu , Rishi M. Shah , Tianna Zhou , Adith S. Arun , Pavan Khosla , Shayaan Kaleem , Anushree Vashist , Bornali Bhattacharjee MS, PhD , Qinglan Ding PhD , Yuan Lu ScD , César Caraballo MD , Frederick Warner PhD , Chenxi Huang PhD , Jeph Herrin PhD , David Putrino PhD , Teresa Michelsen PhD , Liza Fisher , Cynthia Adinig , Akiko Iwasaki PhD , Harlan M. Krumholz MD, SM","doi":"10.1016/j.amjmed.2024.04.015","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The experience of people with long COVID needs further amplification, especially with a comprehensive focus on symptomatology, treatments, and the impact on daily life and finances. Our intent is to describe the experience of people with long COVID symptomatology and characterize the psychological, social, and financial challenges they experience.</div></div><div><h3>Methods</h3><div>We collected data from individuals aged 18 and older reporting long COVID as participants in the Yale Listen to Immune, Symptom and Treatment Experiences Now study. The sample population included 441 participants surveyed between May 2022 and July 2023. We evaluated their demographic characteristics, socioeconomic and psychological status, index infection period, health status, quality of life, symptoms, treatments, prepandemic comorbidities, and new-onset conditions.</div></div><div><h3>Results</h3><div>Overall, the median age of the participants with long COVID was 46 years (interquartile range [IQR]: 38-57 years); 74% were women, 86% were non-Hispanic White, and 93% were from the United States. Participants reported a low health status measured by the Euro-QoL visual analog scale, with a median score of 49 (IQR: 32-61). Participants documented a diverse range of symptoms, with all 96 possible symptom choices being reported. Additionally, participants had tried many treatments (median number of treatments: 19, IQR: 12-28). They were also experiencing psychological distress, social isolation, and financial stress.</div></div><div><h3>Conclusions</h3><div>Despite having tried numerous treatments, participants with long COVID continued to experience an array of health and financial challenges—findings that underscore the failure of the healthcare system to address the medical needs of people with long COVID. These insights highlight the need for crucial medical, mental health, financial, and community support services, as well as further scientific investigation to address the complex impact of long COVID.</div></div>","PeriodicalId":50807,"journal":{"name":"American Journal of Medicine","volume":"138 4","pages":"Pages 712-720.e13"},"PeriodicalIF":5.3000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002934324002389","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The experience of people with long COVID needs further amplification, especially with a comprehensive focus on symptomatology, treatments, and the impact on daily life and finances. Our intent is to describe the experience of people with long COVID symptomatology and characterize the psychological, social, and financial challenges they experience.
Methods
We collected data from individuals aged 18 and older reporting long COVID as participants in the Yale Listen to Immune, Symptom and Treatment Experiences Now study. The sample population included 441 participants surveyed between May 2022 and July 2023. We evaluated their demographic characteristics, socioeconomic and psychological status, index infection period, health status, quality of life, symptoms, treatments, prepandemic comorbidities, and new-onset conditions.
Results
Overall, the median age of the participants with long COVID was 46 years (interquartile range [IQR]: 38-57 years); 74% were women, 86% were non-Hispanic White, and 93% were from the United States. Participants reported a low health status measured by the Euro-QoL visual analog scale, with a median score of 49 (IQR: 32-61). Participants documented a diverse range of symptoms, with all 96 possible symptom choices being reported. Additionally, participants had tried many treatments (median number of treatments: 19, IQR: 12-28). They were also experiencing psychological distress, social isolation, and financial stress.
Conclusions
Despite having tried numerous treatments, participants with long COVID continued to experience an array of health and financial challenges—findings that underscore the failure of the healthcare system to address the medical needs of people with long COVID. These insights highlight the need for crucial medical, mental health, financial, and community support services, as well as further scientific investigation to address the complex impact of long COVID.
期刊介绍:
The American Journal of Medicine - "The Green Journal" - publishes original clinical research of interest to physicians in internal medicine, both in academia and community-based practice. AJM is the official journal of the Alliance for Academic Internal Medicine, a prestigious group comprising internal medicine department chairs at more than 125 medical schools across the U.S. Each issue carries useful reviews as well as seminal articles of immediate interest to the practicing physician, including peer-reviewed, original scientific studies that have direct clinical significance and position papers on health care issues, medical education, and public policy.